bioRxiv Science⌕ Search

Biology subjects

Van Broeckhoven, J.

Publications and source records attributed to Van Broeckhoven, J..

2 recordsLinked to original sources

Internalization of myelin debris by neutrophils fuels inflammation

Progressive neurodegeneration in the central nervous system (CNS) in multiple sclerosis (MS) is driven by chronic inflammatory demyelination. Neutrophils are increasingly recognized as versatile innate immune cells with potentially underappreciated roles in CNS inflammation, but their contribution to MS pathology remains poorly understood. Interestingly, we observed foamy neutrophils in active CNS lesions of MS patients. Therefore, we investigated the ability of human neutrophils to internalize myelin debris and assessed how this impacts their functional phenotype. Neutrophils exhibited efficient myelin uptake, peaking between 3 and 6 hours, predominantly through complement opsonization and internalization via complement receptor 3. Prolonged exposure to high concentrations of myelin induced a pro-inflammatory phenotype, marked by increased production of reactive oxygen species, neutrophil extracellular traps, and inflammatory mediators such as CXCL8 and CCL3. Gene expression analysis revealed a dose-dependent inflammatory signature after myelin uptake, characterized by gradual upregulation of CXCL8 and decreased ARG1 expression, suggesting a shift toward a pro-inflammatory neutrophil phenotype. These findings provide novel insights into the role of neutrophils in myelin clearance and inflammation in the CNS, highlighting complement receptor 3-mediated uptake and downstream pro-inflammatory activation as key mechanisms.

immunology↗

Amelioration of Functional and Histopathological Consequences after Spinal Cord Injury through Phosphodiesterase 4D (PDE4D) Inhibition

Spinal cord injury (SCI) is a life-changing event that severely impacts the patients quality of life. Two key strategies are currently being considered to improve clinical outcomes after SCI: modulation of the neuroinflammatory response, which exacerbates the primary injury, and stimulation of neuro-regenerative repair mechanisms to improve functional recovery. Cyclic adenosine monophosphate (cAMP) is a second messenger crucially involved in both processes. Following SCI, intracellular levels of cAMP are known to decrease over time. Therefore, preventing cAMP degradation represents a promising strategy to suppress inflammation while stimulating regeneration. Intracellular cAMP levels are controlled by its hydrolyzing enzymes phosphodiesterases (PDEs). The PDE4 family is most abundantly expressed in the central nervous system (CNS) and its inhibition has been shown to be therapeutically relevant for managing SCI pathology. Unfortunately, the use of full PDE4 inhibitors at therapeutic doses is associated with severe emetic side effects, hampering their translation toward clinical applications. Therefore, in this study, we evaluated the effect of inhibiting specific PDE4 subtypes (PDE4B and PDE4D) on inflammatory and regenerative processes following SCI, as inhibitors selective for these subtypes have been demonstrated to be well-tolerated. We reveal that administration of the PDE4D inhibitor Gebr32a, but not the PDE4B inhibitor A33, improved functional as well as histopathological outcomes after SCI, comparable to results obtained with the full PDE4 inhibitor roflumilast. Furthermore, using a luminescent human iPSC-derived neurospheroid model, we show that PDE4D inhibition stabilizes neural viability by preventing apoptosis and stimulating neuronal differentiation. These findings strongly suggest that specific PDE4D inhibition offers a novel therapeutic approach for SCI.

neuroscience↗